D.E. Shaw & Co
WST icon

D.E. Shaw & Co’s West Pharmaceutical WST Stock Holding History

D.E. Shaw & Co’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,400
Closed -$986K – 5828
2022
Q1 		$986K Sell
2,400
-13,900
-85% -$5.44M ﹤0.01% 3928
2021
Q4 		$7.64M Buy
16,300
+3,600
+28% +$1.55M 0.01% 1930
2021
Q3 		$5.39M Buy
+12,700
New +$5.35M ﹤0.01% 2048
2020
Q1 		– Sell
-9,300
Closed -$1.4M – 4312
2019
Q4 		$1.4M Sell
9,300
-900
-9% -$131K ﹤0.01% 2754
2019
Q3 		$1.45M Buy
+10,200
New +$1.4M ﹤0.01% 2595

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

D.E. Shaw & Co's WST Position: Q2 2026 in Review

D.E. Shaw & Co reduced its West Pharmaceutical (WST) stake by 7.9% in Q2 2026, selling an estimated $340K and leaving 12,890 shares worth $4.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2472.

D.E. Shaw & Co first reported a position in WST in Q2 2013 and has held it in 37 quarters since. The position peaked at $140M in Q4 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • D.E. Shaw & Co held 12,890 shares of West Pharmaceutical worth $4.63M as of Q2 2026.
  • D.E. Shaw & Co sold 1,111 West Pharmaceutical shares in Q2 2026, an estimated $340K.
  • West Pharmaceutical made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #2472 holding.
  • D.E. Shaw & Co first reported a position in West Pharmaceutical in Q2 2013 and has held it in 37 quarters since.
  • D.E. Shaw & Co's West Pharmaceutical position peaked at $140M in Q4 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.